Skip to main content

Table 1 Percentage of cell types on day 8 as presented in Fig. 5, calculated as mean ± SEM (n = 3) for all mouse groups: 70Z/3-L parent, naïve, LV15Rc.4, and LV15sol.1

From: Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model

Cell population70Z/3 parentnaiveLV15Rc.4LV15sol.1
GFP+ leukemia cells84.84 ± 2.5%n/a6.19 ± 1.4210.91 ± 1.7%
CD4+1.44 ± 0.09%1.74 ± 0.58%2.33 ± 0.68%9.72 ± 0.51
CD8+0.47 ± 0.14%1.11 ± 0.138.08 ± 1.87%18.07 ± 1.9%
NK1.1+4.3 ± 2.54%2.57 ± 0.7347.62 ± 4.96%7.68 ± 0.57%
‘other’8.96 ± 2.7%94.57 ± 1.1235.77 ± 5.86%53.62 ± 1.85%